ATRIUM Partners advised the shareholders of Lactobio in the sale to L’Oréal

Lactobio is a leading probiotic and microbiome research company based in Copenhagen, Denmark. Lactobio was founded in 2017 by Søren Kjærulff, Ph.D. and Charlotte Vedel, Ph.D., who developed a unique, proprietary microbiome discovery platform and screening method to select the most effective and safe strains. These precision probiotics, created from a large biobank of lactobacillus bacteria, will be used in the development of topical formulations containing live bacteria, taking inspiration from nature to impart numerous benefits to skin and hair.

ATRIUM Partners acted as exclusive financial advisor to the shareholders of Lactobio  in the sale to L’Oréal, the world’s leading beauty player with a broad portfolio of 37 international brands, 87,400 employees, a large geographical footprint and sales across all distribution networks. The strategic acquisition builds on 20 years of advanced research by L’Oréal into the microbiome scientific territory, deepening its knowledge of the microorganisms that live on the skin’s surface and reinforcing the group’s leadership in this field. The acquisition opens up new scientific opportunities, including leveraging Lactobio’s microbiome expertise and significant IP portfolio to develop safe and effective new cosmetic solutions using live bacteria.

ATRIUM Partners

Advised in the sale of





MidCap Alliance